Research Interests
Cardiovascular Medicine and HaematologyAPrf Christina Bursill
Grant-Funded Research Associate Professor
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
A/Prof Christina Bursill (BSc (Hons 1) PhD, Adelaide University; Postdoc, Oxford University, UK) is a leader in cardiovascular biology for her expertise in the biology and mechanisms of atherosclerotic plaques, the fatty deposits in the blood vessels of the heart that cause heart attacks. A/Prof Bursill also has expertise in the mechanisms of angiogenesis, the process of new blood vessel formation that is critical for tissue repair following a heart attack and also for wound healing that is impaired in diabetes.She is Director of the Vascular Research Centre at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide and has held two National Heart Foundation (NHF) Fellowships. As CIA she has received >$4.5 million in competitive national research funding in the last 4 years. A/Prof Bursill has published >100 manuscripts, supervised >18 PhD students to completion and currently leads a research team of ten people.A/Prof Bursill is Chair the South Australian Cardiovascular Research network which seeks to bring together cardiovascular researchers from across all South Australia to foster collaboration and drive research excellence and advocacy. She is currently a Board member of the International Atherosclerosis Society and has held positions in the leading cardiovascular bodies nationally including an elected board member (Treasurer) for the Australian Cardiovascular Alliance (ACvA) and was the past-President of the Australian Atherosclerosis Society.
Our group is interested in investigating new mechanisms and targets that underlie the development of fatty deposits in the arteries of the heart, a process called atherosclerosis, that causes heart attacks. We also undertake research looking at the regulation of new blood vessel formation (angiogenesis), which can determine how well a heart attack patient recovers. We have a host on pathophysiologically relevant in vitro and in vivo models established in our laboratory.
Project 1
Title: The effect of fenofibrate on wound healing
Description: Human trials have found that the risk of amputation following a foot ulcer is reduced with fenofibrate (Vitamin B) supplementation. In vitro and in vivo studies have also shown that angiogenesis is increased with the addition of fenofibrate. This study will determine if topically applied fenofibrate increases would healing in an in vivo model established in our laboratory.
Project available for: Honours
Location: SAHMRI
Research project start: Semester 1
Project 2
Title: The role of the glycoprotein receptor ASGR1 in unstable atherosclerosis
Description: A GWAS study has identified that a mutation in ASGR1 reduces the risk of a cardiovascular event by 34%. The mechanisms for this are poorly understood and will be investigated using in vitro and in vivo models in this project.
Project available for: Honours
Location: SAHMRI
Research project start: Semester 1
| Date | Position | Institution name |
|---|---|---|
| 2017 - ongoing | Heart Foundation Lin Huddleston Senior Research Fellow | University of Adelaide |
| 2017 - ongoing | Senior Research Fellow | The University of Adelaide |
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| The University of Adelaide | Australia | BSc | |
| The University of Adelaide | Australia | Hons 1 | |
| University of Adelaide, Adelaide | Australia | PhD |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2017 | Director, Vascular Research Centre | South Australian Health and Medical Research Institute, Adelaide | Australia |
| 2010 - 2016 | Leader Immunobiology Group | The Heart Research Institute, Newtown | Australia |
| 2007 - 2010 | Senior Research Officer | The Heart Research Institute, Newtown | Australia |
| 2001 - 2006 | Postdoctoral Fellow | University of Oxford, Oxford | United Kingdom |
| Year | Citation |
|---|---|
| 2025 | Ruchka, P., Kushwaha, A., Marathe, J. A., Xiang, L., Chen, R., Kirk, R., . . . Li, J. (2025). 3D-printed micro-axicon enables extended depth-of-focus intravascular optical coherence tomography in vivo. Advanced Photonics, 7(2), 026003-1-026003-10. Scopus6 WoS8 |
| 2025 | Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V. A., Stretton, L. G., Solly, E. L., . . . Bursill, C. A. (2025). Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia.. Arterioscler Thromb Vasc Biol, 45(5), 683-701. Scopus1 WoS1 Europe PMC1 |
| 2025 | Wattchow, N. E., Pullen, B. J., Indraratna, A. D., Nankivell, V., Everest-Dass, A., Psaltis, P. J., . . . Bursill, C. A. (2025). The emerging role of glycans and the importance of sialylation in cardiovascular disease. Atherosclerosis, 403, 119172-1-119172-11. Scopus2 WoS2 Europe PMC2 |
| 2025 | Psaltis, P. J., Nguyen, M. T., Singh, K., Sinhal, A., Wong, D. T. L., Alcock, R., . . . Nicholls, S. J. (2025). Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovascular Research, 121(3), 468-478. Scopus19 WoS22 Europe PMC20 |
| 2025 | Chen, R., Rothermel, F., Fitridge, R., Bursill, C. A., Psaltis, P. J., Giessen, H., . . . Li, J. (2025). Low background fluorescence 3D-printed micro-lens for imaging of vulnerable atherosclerotic plaques. APL Photonics, 10(4), 040805-1-040805-10. Scopus2 WoS1 |
| 2025 | Rao, S. R., Salagaras, T., Chen, Y. -C., Bursill, C. A., Peter, K., Snel, M. F., & Psaltis, P. J. (2025). Proteomic Effects of Colchicine on Human Macrophages Loaded With Oxidised Low-Density Lipoprotein Cholesterol.. Heart Lung and Circulation, 34(9), 980-983. |
| 2025 | Nankivell, V. A., Sandeman, L., Stretton, L., Vidanapathirana, A. K., Rajora, M. A., Chen, J., . . . Bursill, C. A. (2025). Theranostic porphyrin nanoparticles identify atherosclerosis via multimodal imaging and elicit atheroprotective effects. Materials Today Bio, 34, 102202. Scopus1 WoS1 Europe PMC1 |
| 2025 | Psaltis, P. J., Nguyen, M. T., Liyanage, S., Salagaras, T., Sharma, S., Di Giovanni, G., . . . Nicholls, S. J. (2025). Persistent inflammation after myocardial infarction: elevated IL-6 associates with impaired coronary plaque stabilization despite optimal therapy. European Journal of Preventive Cardiology, zwaf563-1-zwaf563-4. |
| 2025 | Thomas, J. M., Bamhare, P., Mulangala, J., Bursill, C. A., Nicholls, S. J., Di Bartolo, B. A., & Bubb, K. J. (2025). Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease.. FASEB J, 39(18), e71058. |
| 2025 | Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a Novel Murine Model of In-Stent Neoatherosclerosis. Journal of the American Heart Association, 14(22), e041260. Scopus1 WoS1 Europe PMC1 |
| 2025 | Liu, J., & Bursill, C. (2025). When stents become plaques: in-stent neoatherosclerosis.. Nature reviews. Cardiology, 1 page. |
| 2025 | Allahwala, M. A., Wattchow, N., Dwyer, A., Wong, D. T. L., Bursill, C., Marathe, J. A., & Psaltis, P. J. (2025). Unappreciated Coronary Artery Ectasia Leading to Stent Failure. Jacc Case Reports, 106313. |
| 2025 | White, J. B., Lin, A., Montarello, N. J., Bursill, C. A., Figtree, G. A., Dey, D., . . . Psaltis, P. J. (2025). Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction.. Atherosclerosis, 408, 120421. |
| 2025 | Xiang, L., Chen, R., Tan, J. T. M., Nankivell, V., Bursill, C. A., McLaughlin, R. A., & Li, J. (2025). Identification and removal of system-induced autofluorescence in miniaturized fiber-optic fluorescence endoscopes. PNAS Nexus, 4(8), pgaf226-1-pgaf226-10. |
| 2025 | Psaltis, J. P., Marathe, J. A., Nguyen, M. T., Le, R., Bursill, C. A., Marathe, C. S., . . . Psaltis, P. J. (2025). Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future. Medicinal Research Reviews, 45(1), 29-65. Scopus16 WoS16 Europe PMC14 |
| 2024 | Williamson, A. E., Liyanage, S., Hassanshahi, M., Dona, M. S. I., Toledo-Flores, D., Tran, D. X. A., . . . Psaltis, P. J. (2024). Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nature Communications, 15(1), 7097-1-7097-21. Scopus6 WoS8 Europe PMC6 |
| 2024 | Chen, R., Sandeman, L., Nankivell, V., Tan, J. T. M., Rashidi, M., Psaltis, P. J., . . . Li, J. (2024). Detection of atherosclerotic plaques with HDL-like porphyrin nanoparticles using an intravascular dual-modality optical coherence tomography and fluorescence system. Scientific Reports, 14(1), 12359-1-12359-10. Scopus8 WoS5 Europe PMC3 |
| 2024 | Moore, E., Robson, A. J., Crisp, A. R., Cockshell, M. P., Burzava, A. L. S., Ganesan, R., . . . Bonder, C. S. (2024). Study of the Structure of Hyperbranched Polyglycerol Coatings and their Anti-Biofouling and Anti-Thrombotic Applications. Advanced Healthcare Materials, 13(26), 2401545-1-2401545-23. Scopus2 WoS2 Europe PMC1 |
| 2024 | Tan, J. T. M., Cheney, C. V., Bamhare, N. E. S., Hossin, T., Bilu, C., Sandeman, L., . . . Bursill, C. A. (2024). Female Psammomys obesus Are Protected from Circadian Disruption-Induced Glucose Intolerance, Cardiac Fibrosis and Adipocyte Dysfunction. International Journal of Molecular Sciences, 25(13), 7265-1-7265-19. Scopus4 WoS4 Europe PMC4 |
| 2024 | Tan, J. T. M., Price, K. J., Fanshaw, S. -R., Bilu, C., Pham, Q. T., Pham, A., . . . Bursill, C. A. (2024). Exercise Reduces Glucose Intolerance, Cardiac Inflammation and Adipose Tissue Dysfunction in Psammomys obesus Exposed to Short Photoperiod and High Energy Diet. International Journal of Molecular Sciences, 25(14), 7756-1-7756-13. Scopus4 WoS3 Europe PMC3 |
| 2024 | Nankivell, V., Vidanapathirana, A. K., Hoogendoorn, A., Tan, J. T. M., Verjans, J., Psaltis, P. J., . . . Bursill, C. A. (2024). Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease. Cardiovascular Research, 120(8), 819-838. Scopus22 WoS20 Europe PMC18 |
| 2024 | Hansen, T. S., Galougahi, K. K., Tang, O., Tsang, M., Scherrer-Crosbie, M., Arystarkhova, E., . . . Figtree, G. A. (2024). The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodeling via redox and inflammatory mechanisms. American Journal of Physiology: Heart and Circulatory Physiology, 326(3), H623-H635. Scopus2 WoS2 Europe PMC2 |
| 2024 | Wong, N. K. P., Solly, E. L., Le, R., Nankivell, V. A., Mulangala, J., Psaltis, P. J., . . . Tan, J. T. M. (2024). TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. International Journal of Molecular Sciences, 25(6), 3343. Scopus1 WoS1 Europe PMC1 |
| 2024 | Lotfollahi, Z., Tan, J. T. M., Nankivell, V. A., Sandeman, L., Liyanage, S., Solly, E. L., . . . Bursill, C. A. (2024). Topical Reconstituted High-Density Lipoproteins Elicit Anti-Inflammatory Effects in Diabetic Wounds. Adv Wound Care (New Rochelle), 1-16. |
| 2023 | Cartland, S. P., Stanley, C. P., Bursill, C., Passam, F., Figtree, G. A., Patel, S., . . . Kavurma, M. M. (2023). Sex, Endothelial Cell Functions, and Peripheral Artery Disease. International Journal of Molecular Sciences, 24(24), 17439-1-17439-14. Scopus13 WoS12 Europe PMC11 |
| 2023 | Bursill, C. A. (2023). NDRG1: A New Regulator of Vascular Inflammation and Atherothrombosis. Circulation Research, 132(3), 320-322. Scopus2 WoS2 Europe PMC2 |
| 2023 | Schwarz, N., Fernando, S., Chen, Y. -C., Salagaras, T., Rao, S. R., Liyanage, S., . . . Psaltis, P. J. (2023). Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. The FASEB Journal, 37(4), 1-20. Scopus56 WoS54 Europe PMC44 |
| 2022 | Kavurma, M. M., Bursill, C., Stanley, C. P., Passam, F., Cartland, S. P., Patel, S., . . . Robinson, D. A. (2022). Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease. Frontiers in Cardiovascular Medicine, 9, 1-15. Scopus30 WoS29 Europe PMC27 |
| 2022 | Fernando, S., Salagaras, T., Schwarz, N., Sandeman, L., Tan, J. T. M., Xie, J., . . . Psaltis, P. J. (2022). Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36. The FASEB Journal, 36(2), 1-19. Scopus4 WoS5 Europe PMC3 |
| 2022 | Li, J., Thiele, S., Kirk, R. W., Quirk, B. C., Hoogendoorn, A., Chen, Y. C., . . . McLaughlin, R. A. (2022). 3D-printed micro lens-in-lens for in vivo multimodal microendoscopy. Small, 18(17), 2107032-1-2107032-8. Scopus64 WoS58 Europe PMC25 |
| 2022 | Agbaedeng, T. A., Zacharia, A. L., Iroga, P. E., Rathnasekara, V. M., Munawar, D. A., Bursill, C., & Noubiap, J. J. (2022). Associations between adipokines and atrial fibrillation: A systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 32(4), 853-862. Scopus11 WoS11 Europe PMC8 |
| 2022 | Clare, J., Ganly, J., Bursill, C. A., Sumer, H., Kingshott, P., & de Haan, J. B. (2022). The mechanisms of restenosis and relevance to next generation stent design. Biomolecules, 12(3), 430-1-430-26. Scopus54 WoS51 Europe PMC38 |
| 2022 | Mulangala, J., Akers, E. J., Solly, E. L., Bamhare, P. M., Wilsdon, L. A., Wong, N. K. P., . . . Di Bartolo, B. A. (2022). Pro-Calcific Environment Impairs Ischaemia-Driven Angiogenesis.. International journal of molecular sciences, 23(6), 1-21. Scopus3 WoS1 Europe PMC1 |
| 2022 | Stanton, K. M., Liu, H., Kienzle, V., Bursill, C., Bao, S., & Celermajer, D. S. (2022). The Effects of Exercise on Plaque Volume and Composition in a Mouse Model of Early and Late Life Atherosclerosis. Frontiers in Cardiovascular Medicine, 9, 1-10. Scopus7 WoS7 Europe PMC6 |
| 2022 | Vidanapathirana, A. K., Goyne, J. M., Williamson, A. E., Pullen, B. J., Chhay, P., Sandeman, L., . . . Bursill, C. A. (2022). Biological Sensing of Nitric Oxide in Macrophages and Atherosclerosis Using a Ruthenium-Based Sensor. Biomedicines, 10(8), 1807. Scopus8 WoS7 Europe PMC6 |
| 2022 | Bursill, C. A., Smith, N. J., Palpant, N., Tan, I., Sunde, M., Harvey, R. P., . . . Australian Cardiovascular Alliance. (2022). Don't Turn Off the Tap! The Importance of Discovery Science to the Australian Cardiovascular Sector and Improving Clinical Outcomes Into the Future.. Heart, lung & circulation, 31(10), S1443-9506(22)00976-3. Scopus1 WoS1 Europe PMC1 |
| 2022 | Staikopoulos, V., Zhang, X., Pullen, B. P., Reineck, P., Vidanapathirana, A. K., Lee, S. M., . . . Abell, A. D. (2022). Multi-coloured fluorescent sensing toolbox for selective detection of nitroxyl <i>in vitro</i> and <i>ex vivo</i>. Sensors & Diagnostics, 1(2), 280-293. Scopus1 WoS1 |
| 2022 | Li, J., Montarello, N., Hoogendoorn, A., Verjans, J., Bursill, C., Peter, K., . . . Psaltis, P. (2022). Multimodality intravascular imaging of high-risk coronary plaque. JACC: Cardiovascular Imaging, 15(1), 145-159. Scopus58 WoS57 Europe PMC45 |
| 2021 | Nankivell, V. A., Tan, J. T. M., Wilsdon, L. A., Morrison, K. R., Bilu, C., Psaltis, P. J., . . . Brown, A. (2021). Circadian disruption by short light exposure and a high energy diet impairs glucose tolerance and increases cardiac fibrosis in Psammomys obesus. Scientific reports, 11(1), 1-13. Scopus14 WoS14 Europe PMC12 |
| 2021 | Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., . . . Psaltis, P. (2021). Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians.. Intern Med J, 51(5), 769-779. Scopus7 WoS6 Europe PMC5 |
| 2021 | Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., . . . Pang, J. (2021). Synopsis of an Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia: an Australian Perspective. American Journal of Preventive Cardiology, 6, 100151-1-100151-9. Scopus6 WoS7 Europe PMC3 |
| 2021 | Hoogendoorn, A., Avery, T. D., Li, J., Bursill, C., Abell, A., & Grace, P. M. (2021). Emerging therapeutic applications for fumarates. Trends in Pharmacological Sciences, 42(4), 239-254. Scopus26 WoS30 Europe PMC26 |
| 2021 | Morrison, K. R., Solly, E. L., Shemesh, T., Psaltis, P. J., Nicholls, S. J., Brown, A., . . . Tan, J. T. M. (2021). Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people. Diabetologia, 64(6), 1402-1411. Scopus18 WoS19 Europe PMC18 |
| 2021 | Pisaniello, A. D., Psaltis, P. J., King, P. M., Liu, G., Gibson, R. A., Tan, J. T. M., . . . Di Bartolo, B. A. (2021). Omega-3 fatty acids ameliorate vascular inflammation: a rationale for their atheroprotective effects. Atherosclerosis, 324, 27-37. Scopus38 WoS37 Europe PMC32 |
| 2021 | Vidanapathirana, A. K., Psaltis, P. J., Bursill, C. A., Abell, A. D., & Nicholls, S. J. (2021). Cardiovascular bioimaging of nitric oxide: achievements, challenges, and the future. Medicinal research reviews, 41(1), 435-463. Scopus38 WoS34 Europe PMC25 |
| 2021 | Ravindran, D., Galougahi, K. K., Tan, J. T. M., Kavurma, M. M., & Bursill, C. A. (2021). The Multiple Roles of Chemokines in the Mechanisms of Stent Biocompatibility.. Cardiovasc Res, 117(11), 2299-2308. Scopus6 Europe PMC5 |
| 2021 | Solly, E. L., Psaltis, P. J., Bursill, C. A., & Tan, J. T. M. (2021). The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications. Frontiers in Pharmacology, 12, 718679-1-718679-16. Scopus20 WoS18 Europe PMC15 |
| 2020 | Primer, K. R., Psaltis, P. J., Tan, J. T. M., & Bursill, C. A. (2020). The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis.. Int J Mol Sci, 21(10), 1-21. Scopus30 WoS27 Europe PMC27 |
| 2020 | Khalid, A., Bai, D., Abraham, A. N., Jadhav, A., Linklater, D., Matusica, A., . . . Gibson, B. C. (2020). Electrospun nanodiamond-silk fibroin membranes: a multifunctional platform for biosensing and wound-healing applications. ACS Appl Mater Interfaces, 12(43), 48408-48419. Scopus83 WoS73 Europe PMC46 |
| 2020 | Lotfollahi, Z., Dawson, J., Fitridge, R., & Bursill, C. (2020). The anti-inflammatory and pro-angiogenic properties of high-density lipoproteins (HDL): an emerging role in diabetic wound healing.. Adv Wound Care (New Rochelle), 10(7), 370-380. Scopus18 WoS18 Europe PMC14 |
| 2020 | Li, J., Thiele, S., Quirk, B. C., Kirk, R. W., Verjans, J. W., Akers, E., . . . McLaughlin, R. A. (2020). Ultrathin monolithic 3D printed optical coherence tomography endoscopy for preclinical and clinical use. Light: Science and Applications, 9(1), 124-1-124-10. Scopus152 WoS141 Europe PMC49 |
| 2020 | Li, J., Thiele, S., Quirk, B. C., Kirk, R. W., Verjans, J. W., Akers, E., . . . McLaughlin, R. A. (2020). Ultrathin monolithic 3D printed optical coherence tomography endoscopy for preclinical and clinical use.. Light, science & applications, 9(1), 124. |
| 2020 | Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., . . . FH Australasia Network Consensus Working Group. (2020). Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.. Heart Lung Circ, 30(3), 324-349. Scopus88 WoS80 Europe PMC71 |
| 2019 | Takata, K., Honda, S., Sidharta, S. L., MyNgan, D., Shishikura, D., Kim, S. W., . . . Nicholls, S. J. (2019). Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 9(4), 310. Scopus10 WoS9 Europe PMC9 |
| 2019 | Liu, G., Bursill, C., Cartland, S. P., Anwer, A. G., Parker, L. M., Zhang, K., . . . Goldys, E. M. (2019). A nanoparticle-based affinity sensor that identifies and selects highly cytokine-secreting cells. iScience, 20, 137-147. Scopus17 WoS17 Europe PMC13 |
| 2019 | Ravindran, D., Cartland, S. P., Bursill, C. A., & Kavurma, M. M. (2019). Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(12), 13423-13434. Scopus7 WoS5 Europe PMC8 |
| 2019 | Tan, J. T. M., Nankivell, V. A., Bilu, C., Shemesh, T., Nicholls, S. J., Zimmet, P., . . . Bursill, C. A. (2019). High-Energy Diet and Shorter Light Exposure Drives Markers of Adipocyte Dysfunction in Visceral and Subcutaneous Adipose Depots of Psammomys obesus.. Int J Mol Sci, 20(24), 17 pages. Scopus15 WoS14 Europe PMC12 |
| 2019 | Solly, E. L., Dimasi, C. G., Bursill, C. A., Psaltis, P. J., & Tan, J. T. M. (2019). MicroRNAs as therapeutic targets and clinical biomarkers in atherosclerosis. Journal of Clinical Medicine, 8(12), 2199-1-2199-26. Scopus53 WoS51 Europe PMC43 |
| 2019 | Vidanapathirana, A. K., Pullen, B. J., Zhang, R., Duong, M. N., Goyne, J. M., Zhang, X., . . . Psaltis, P. J. (2019). A novel ruthenium-based molecular sensor to detect endothelial nitric oxide. Scientific Reports, 9(1, article no. 1720), 1720-1-1720-16. Scopus9 WoS8 Europe PMC8 |
| 2019 | Yuan, J., Tan, J. T. M., Rajamani, K., Solly, E. L., King, E. J., Lecce, L., . . . Ng, M. K. C. (2019). Fenofibrate rescues diabetes-related impairment of ischemia-mediated angiogenesis by PPARα-independent modulation of thioredoxin-interacting protein. Diabetes, 68(5), 1040-1053. Scopus21 WoS21 Europe PMC20 |
| 2019 | Toledo-Flores, D., Williamson, A., Schwarz, N., Fernando, S., Dimasi, C., Witt, T. A., . . . Psaltis, P. J. (2019). Vasculogenic properties of adventitial Sca-1⁺CD45⁺ progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis. Scientific Reports, 9(1), 7286-1-7286-15. Scopus22 WoS21 Europe PMC20 |
| 2019 | MacEr-Wright, J. L., Stanley, N. R., Portman, N., Tan, J. T., Bursill, C., Rayner, B. S., & Hawkins, C. L. (2019). A role for chlorinated nucleosides in the perturbation of macrophage function and promotion of inflammation. Chemical Research in Toxicology, 32(6), 1223-1234. Scopus16 WoS12 Europe PMC11 |
| 2019 | Nguyen, M. T., Fernando, S., Schwarz, N., Tan, J. T. M., Bursill, C. A., & Psaltis, P. J. (2019). Inflammation as a therapeutic target in atherosclerosis. Journal of Clinical Medicine, 8(8), 1109-1-1109-20. Scopus149 WoS136 Europe PMC108 |
| 2018 | Ridiandries, A., Tan, J. T. M., & Bursill, C. A. (2018). The role of chemokines in wound healing. International Journal of Molecular Sciences, 19(10), 20 pages. Scopus381 WoS348 Europe PMC301 |
| 2018 | Wong, N., Nicholls, S., Tan, J., & Bursill, C. (2018). The role of high-density lipoproteins in diabetes and its vascular complications. International Journal of Molecular Sciences, 19(6), 21 pages. Scopus61 WoS47 Europe PMC48 |
| 2018 | Wong, N. K. P., Cheung, H., Solly, E. L., Vanags, L. Z., Ritchie, W., Nicholls, S. J., . . . Tan, J. T. M. (2018). Exploring the roles of CREBRF and TRIM2 in the regulation of angiogenesis by high-density lipoproteins. International Journal of Molecular Sciences, 19(7), 1903-1-1903-17. Scopus16 WoS16 Europe PMC16 |
| 2018 | Clayton, Z., Tan, R., Miravet, M., Lennartsson, K., Cooke, J., Bursill, C., . . . Patel, S. (2018). Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model. Bioscience Reports, 38(4), BSR20180563-1-BSR20180563-11. Scopus63 WoS55 Europe PMC52 |
| 2018 | Hourigan, S. T., Solly, E. L., Nankivell, V. A., Ridiandries, A., Weimann, B., Henriquez, R., . . . Tan, J. T. M. (2018). The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis. Scientific Reports, 8(1), 13596. Scopus26 WoS25 Europe PMC21 |
| 2018 | Duong, M., Uno, K., Nankivell, V., Bursill, C., & Nicholls, S. (2018). Induction of obesity impairs reverse cholesterol transport in ob/ob mice. PLoS ONE, 13(9), 17 pages. Scopus25 WoS20 Europe PMC18 |
| 2018 | Di Bartolo, B., Psaltis, P., Bursill, C., & Nicholls, S. (2018). Translating evidence of HDL and plaque regression. Arteriosclerosis, thrombosis, and vascular biology, 38(9), 1961-1968. Scopus23 WoS23 Europe PMC20 |
| 2018 | Vanags, L. Z., Wong, N. K. P., Nicholls, S. J., & Bursill, C. A. (2018). High-density lipoproteins and apolipoprotein A-I improve stent biocompatibility: recent evidence from experimental models and clinical studies. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(8), 1691-1701. Scopus16 WoS14 Europe PMC16 |
| 2018 | Cannizzo, C. M., Adonopulos, A. A., Solly, E. L., Ridiandries, A., Vanags, L. Z., Mulangala, J., . . . Tan, J. T. (2018). VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia. FASEB Journal, 32(6), 2911-2922. Scopus11 WoS11 Europe PMC10 |
| 2018 | Chen, X., Duong, M., Nicholls, S., & Bursill, C. (2018). Myeloperoxidase modification of high-density lipoprotein suppresses human endothelial cell proliferation and migration via inhibition of ERK1/2 and Akt activation. Atherosclerosis, 273, 75-83. Scopus11 WoS10 Europe PMC8 |
| 2018 | Vanags, L. Z., Tan, J. T. M., Galougahi, K. K., Schaefer, A., Wise, S. G., Murphy, A., . . . Bursill, C. A. (2018). Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype. JACC: Basic to Translational Science, 3(2), 200-209. Scopus20 WoS18 Europe PMC16 |
| 2018 | Morton, J., Bao, S., Vanags, L., Tsatralis, T., Ridiandries, A., Siu, C., . . . Bursill, C. (2018). Strikingly different atheroprotective effects of apolipoprotein A-I in early- versus late-stage atherosclerosis. JACC: Basic to Translational Science, 3(2), 187-199. Scopus18 WoS17 Europe PMC15 |
| 2017 | Chen, X., Duong, M., Psaltis, P., Bursill, C., & Nicholls, S. (2017). High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes. Cardiovascular Diabetology, 16(1), 121-1-121-9. Scopus17 WoS19 Europe PMC17 |
| 2017 | Chalmers, A., Bursill, C., & Myerscough, M. (2017). Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression. PLoS ONE, 12(11), e0187674-1-e0187674-23. Scopus38 WoS29 Europe PMC21 |
| 2017 | Chung, R., Wang, Z., Bursill, C., Wu, B., Barter, P., & Rye, K. (2017). Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice. PLoS ONE, 12(12), 1-13. Scopus33 WoS27 Europe PMC19 |
| 2017 | Vanags, L. Z., Tan, J. T. M., Santos, M., Michael, P. S., Ali, Z., Bilek, M. M. M., . . . Bursill, C. A. (2017). Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility. Nanomedicine: Nanotechnology, Biology, and Medicine, 13(7), 2141-2150. Scopus10 WoS9 Europe PMC6 |
| 2017 | Ridiandries, A., Bursill, C., & Tan, J. (2017). Broad-spectrum inhibition of the CC-chemokine class improves wound healing and wound angiogenesis. International Journal of Molecular Sciences, 18(1), 155-1-155-15. Scopus36 WoS27 Europe PMC25 |
| 2017 | Ridiandries, A., Tan, J., Ravindran, D., Williams, H., Medbury, H., Lindsay, L., . . . Bursill, C. (2017). CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis. FASEB Journal, 31(3), 1179-1192. Scopus14 WoS13 Europe PMC14 |
| 2017 | van der Vorst, E., Theodorou, K., Wu, Y., Hoeksema, M., Goossens, P., Bursill, C., . . . Donners, M. (2017). High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling. Cell Metabolism, 25(1), 197-207. Scopus112 WoS105 Europe PMC98 |
| 2017 | Tan, J. T. M., Prosser, H. C. G., Dunn, L. L., Vanags, L. Z., Ridiandries, A., Tsatralis, T., . . . Bursill, C. A. (2017). High-Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor Class B Type I (vol 65, pg 3091, 2016). DIABETES, 66(4), 1 page. Europe PMC1 |
| 2017 | Ravindran, D., Ridiandries, A., Vanags, L., Henriquez, R., Cartland, S., Tan, J., & Bursill, C. (2017). Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice. PLoS ONE, 12(3), e0173224-1-e0173224-23. Scopus20 WoS20 Europe PMC18 |
| 2017 | Chan, A., Tan, R., Michael, P., Lee, B., Vanags, L., Ng, M., . . . Wise, S. (2017). Evaluation of synthetic vascular grafts in a mouse carotid grafting model. PLoS ONE, 12(3), e0174773-1-e0174773-15. Scopus23 WoS20 Europe PMC18 |
| 2016 | Arnott, C., Punnia-Moorthy, G., Tan, J., Sadeghipour, S., Bursill, C., & Patel, S. (2016). The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells. PLOS ONE, 11(3), e0150688. Scopus22 WoS24 Europe PMC19 |
| 2016 | Ridiandries, A., Tan, J., & Bursill, C. (2016). The role of CC-chemokines in the regulation of angiogenesis. International Journal of Molecular Sciences, 17(11), 1856-1-1856-16. Scopus94 WoS87 Europe PMC77 |
| 2016 | Tsatralis, T., Ridiandries, A., Robertson, S., Vanags, L., Lam, Y., Tan, J. T., . . . Bursill, C. (2016). Reconstituted high-density lipoproteins promote wound repair and blood flow recovery in response to ischemia in aged mice. Lipids in Health and Disease, 15(1), 150-1-150-12. Scopus20 WoS17 Europe PMC19 |
| 2016 | Tan, J., Prosser, H., Dunn, L., Vanags, L., Ridiandries, A., Tsatralis, T., . . . Bursill, C. (2016). High-density lipoproteins rescue diabetes-impaired angiogenesis via scavenger receptor Class B Type I. Diabetes, 65(10), 3091-3103. Scopus42 WoS41 Europe PMC36 |
| 2016 | Lam, Y., Lecce, L., Tan, J., Bursill, C., Handelsman, D., & Ng, M. (2016). Androgen receptor-mediated genomic androgen action augments ischemia-induced neovascularization. Endocrinology, 157(12), 4853-4864. Scopus8 WoS7 Europe PMC6 |
| 2016 | Robertson, S., Martínez, G., Payet, C., Barraclough, J., Celermajer, D., Bursill, C., & Patel, S. (2016). Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clinical Science, 130(14), 1237-1246. Scopus145 WoS129 Europe PMC113 |
| 2015 | Martínez, G., Robertson, S., Barraclough, J., Xia, Q., Mallat, Z., Bursill, C., . . . Patel, S. (2015). Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. Journal of the American Heart Association, 4(8), e002128-1-e002128-10. Scopus258 WoS235 Europe PMC197 |
| 2015 | Chalmers, A., Cohen, A., Bursill, C., & Myerscough, M. (2015). Bifurcation and dynamics in a mathematical model of early atherosclerosis: how acute inflammation drives lesion development. Journal of Mathematical Biology, 71(6), 1451-1480. Scopus51 WoS44 Europe PMC28 |
| 2015 | Kim, C., Mitchell, J., Bursill, C., Sowers, A., Thetford, A., Cook, J., . . . Davies, M. (2015). The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE¯⁄¯mice. Atherosclerosis, 240(1), 234-241. Scopus50 WoS45 Europe PMC36 |
| 2015 | Tan, J., Ng, M., & Bursill, C. (2015). The role of high-density lipoproteins in the regulation of angiogenesis. Cardiovascular Research, 106(2), 184-193. Scopus44 WoS40 Europe PMC37 |
| 2014 | Dunn, L., Simpson, P., Prosser, H., Lecce, L., Yuen, G., Buckle, A., . . . Ng, M. (2014). A critical role for Thioredoxin- Interacting protein in diabetes-related impairment of angiogenesis. Diabetes, 63(2), 675-687. Scopus60 WoS57 Europe PMC52 |
| 2014 | Brown, B., Kim, C., Torpy, F., Bursill, C., McRobb, L., Heather, A., . . . Van Reyk, D. (2014). Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E-/- mice. Atherosclerosis, 232(2), 403-409. Scopus58 WoS56 Europe PMC41 |
| 2014 | Prosser, H., Tan, J., Dunn, L., Patel, S., Vanags, L., Bao, S., . . . Bursill, C. (2014). Multifunctional regulation of angiogenesis by high-density lipoproteins. Cardiovascular Research, 101(1), 145-154. Scopus44 WoS41 Europe PMC36 |
| 2014 | Tan, J., Hamish, H., Vanags, L., Monger, S., Ng, M., & Bursill, C. (2014). High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α. FASEB Journal, 28(1), 206-217. Scopus57 WoS52 Europe PMC52 |
| 2013 | Van Der Vorst, E., Vanags, L., Dunn, L., Prosser, H., Rye, K., & Bursill, C. (2013). High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells. FASEB Journal, 27(4), 1413-1425. Scopus52 WoS47 Europe PMC45 |
| 2013 | Dunn, L., Prosser, H., Tan, J., Vanags, L., Ng, M., & Bursill, C. (2013). Murine model of wound healing. Journal of Visualized Experiments, 2013(75), 1-6. Scopus228 WoS218 Europe PMC129 |
| 2013 | Dunn, L., Prosser, H., Tan, J., Vanags, L., Ng, M., & Bursill, C. (2013). Murine model of wound healing. Journal of visualized experiments : JoVE, (75), e50265. Scopus44 |
| 2013 | Ali, Z. A., Rinze, R., Douglas, G., Hu, Y., Xiao, Q., Qi, W., . . . Channon, K. M. (2013). Tetrahydrobiopterin determines vascular remodeling through enhanced endothelial cell survival and regeneration. Circulation, 128(SUPPL.1), S50-S58. Scopus20 WoS18 Europe PMC15 |
| 2012 | Prosser, H., Ng, M., & Bursill, C. (2012). The role of cholesterol efflux in mechanisms of endothelial protection by HDL. Current Opinion in Lipidology, 23(3), 182-189. Scopus60 WoS56 Europe PMC49 |
| 2011 | Akram, O. N., Bursill, C., Desai, R., Heather, A. K., Kazlauskas, R., Handelsman, D. J., & Lambert, G. (2011). Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays. Analytical Chemistry, 83(6), 2065-2074. Scopus45 WoS40 Europe PMC29 |
| 2011 | Di Bartolo, B., Vanags, L., Tan, J., Bao, S., Rye, K., Barter, P., & Bursill, C. (2011). The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.. Lipids in health and disease, 10(1), 224. Scopus30 WoS28 Europe PMC20 |
| 2011 | Di Bartolo, B., Nicholls, S., Bao, S., Rye, K., Heather, A., Barter, P., & Bursill, C. (2011). The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis, 217(2), 395-400. Scopus62 WoS62 Europe PMC54 |
| 2010 | Bursill, C. A., Castro, M. L., Beattie, D. T., Nakhla, S., Van Der Vorst, E., Heather, A. K., . . . Rye, K. A. (2010). High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arteriosclerosis Thrombosis and Vascular Biology, 30(9), 1773-1778. Scopus119 WoS112 Europe PMC113 |
| 2009 | Rye, K. A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009). The metabolism and anti-atherogenic properties of HDL. Journal of Lipid Research, 50(SUPPL.), S195-S200. Scopus262 WoS250 Europe PMC208 |
| 2009 | Seki, E., De Minicis, S., Gwak, G. Y., Kluwe, J., Inokuchi, S., Bursill, C. A., . . . Schwabe, R. F. (2009). CCR1 and CCR5 promote hepatic fibrosis in mice. Journal of Clinical Investigation, 119(7), 1858-1870. Scopus395 WoS364 Europe PMC332 |
| 2009 | Bursill, C. A., McNeill, E., Wang, L., Hibbitt, O. C., Wade-Martins, R., Paterson, D. J., . . . Channon, K. M. (2009). Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition. Gene Therapy, 16(1), 93-102. Scopus34 WoS32 Europe PMC28 |
| 2009 | Stevenson, N. J., Addley, M. R., Ryan, E. J., Boyd, C. R., Carroll, H. P., Paunovic, V., . . . Johnston, J. A. (2009). CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression. Journal of Leukocyte Biology, 85(2), 289-297. Scopus31 WoS31 Europe PMC23 |
| 2008 | McAteer, M. A., Schneider, J. E., Ali, Z. A., Warrick, N., Bursill, C. A., Von Zur Muhlen, C., . . . Choudhury, R. P. (2008). Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arteriosclerosis Thrombosis and Vascular Biology, 28(1), 77-83. Scopus231 WoS208 Europe PMC167 |
| 2008 | Ali, Z. A., Bursill, C. A., Douglas, G., McNeil, E., Papaspyridonos, M., Tatham, A. L., . . . Channon, K. M. (2008). CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis. Circulation, 118(14 Suppl), S71-S77. |
| 2007 | Bursill, C. A., & Roach, P. D. (2007). A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids, 42(7), 621-627. Scopus50 WoS51 Europe PMC34 |
| 2007 | Hibbitt, O. C., Harbottle, R. P., Waddington, S. N., Bursill, C. A., Coutelle, C., Channon, K. M., & Wade-Martins, R. (2007). Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection. Journal of Gene Medicine, 9(6), 488-497. Scopus41 WoS36 Europe PMC31 |
| 2007 | Bursill, C. A., Abbey, M., & Roach, P. D. (2007). A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis, 193(1), 86-93. Scopus129 WoS103 Europe PMC71 |
| 2006 | Bursill, C. A., & Roach, P. D. (2006). Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. Journal of Agricultural and Food Chemistry, 54(5), 1621-1626. Scopus88 WoS77 Europe PMC61 |
| 2006 | Ali, T., Humphries, J., Burnand, K., Sawyer, B., Bursill, C., Channon, K., . . . Smith, A. (2006). Monocyte recruitment in venous thrombus resolution. Journal of Vascular Surgery, 43(3), 601-608. Scopus76 WoS71 Europe PMC62 |
| 2006 | Bursill, C. A., Cash, J. L., Channon, K. M., & Greaves, D. R. (2006). Membrane-bound CC chemokine inhibitor 35k provides localized inhibition of CC chemokine activity in vitro and in vivo. Journal of Immunology, 177(8), 5567-5573. Scopus17 WoS15 Europe PMC10 |
| 2005 | Ali, Z. A., Bursill, C. A., Hu, Y., Choudhury, R. P., Xu, Q., Greaves, D. R., & Channon, K. M. (2005). Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice. Circulation, 112(9 SUPPL.), I235-I241. Scopus41 WoS35 Europe PMC24 |
| 2005 | Puhakka, H. L., Turunen, P., Gruchala, M., Bursill, C., Heikura, T., Vajanto, I., . . . Ylä-Herttuala, S. (2005). Effects of vaccinia virus anti-inflammatory protein 35K and TIMP-1 gene transfers on vein graft stenosis in rabbits. In Vivo, 19(3), 515-522. Scopus23 WoS18 Europe PMC11 |
| 2004 | Bursill, C. A., Channon, K. M., & Greaves, D. R. (2004). The role of chemokines in atherosclerosis: Recent evidence from experimental models and population genetics. Current Opinion in Lipidology, 15(2), 145-149. Scopus99 WoS87 Europe PMC78 |
| 2004 | Bursill, C. A., Choudhury, R. P., Ali, Z., Greaves, D. R., & Channon, K. M. (2004). Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice. Circulation, 110(16), 2460-2466. Scopus65 WoS62 Europe PMC50 |
| 2003 | Lucas, A. D., Bursill, C., Guzik, T. J., Sadowski, J., Channon, K. M., & Greaves, D. R. (2003). Smooth Muscle Cells in Human Atherosclerotic Plaques Express the Fractalkine Receptor CX3CR1 and Undergo Chemotaxis to the CX 3C Chemokine Fractalkine (CX3CL1). Circulation, 108(20), 2498-2504. Scopus152 WoS145 Europe PMC117 |
| 2003 | Bursill, C. A., Cai, S., Channon, K. M., & Greaves, D. R. (2003). Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo. Immunobiology, 207(3), 187-196. Scopus36 WoS35 Europe PMC23 |
| 2001 | Bursill, C., Roach, P., Bottema, C., & Pal, S. (2001). Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. Journal of Agricultural and Food Chemistry, 49(11), 5639-5645. Scopus60 WoS44 Europe PMC36 |
| - | Wattchow, N. E., Salagaras, T., Nguyen, M. T., Sandeman, L. Y. -J., Figtree, G. A., Di Giovanni, G., . . . Psaltis, P. J. (n.d.). Syndecan-1, Endocan and Non-Culprit Coronary Plaque Composition Following Non-St Elevation Myocardial Infarction. |
| Year | Citation |
|---|---|
| 2020 | Nankivell, V., Primer, K., Vidanapathirana, A., Psaltis, P., & Bursill, C. (2020). Vascular Biology of Smooth Muscle Cells and Restenosis. In R. Fitridge (Ed.), Mechanisms of Vascular Disease A Textbook for Vascular Specialists (3rd ed., pp. 117-139). Cham, Switzerland: Springer. Scopus6 |
| 2020 | Wong, N. K. P., Solly, E. L., Bursill, C. A., Tan, J. T. M., & Ng, M. K. C. (2020). Pathophysiology of Angiogenesis and Its Role in Vascular Disease. In N. K. P. Wong (Ed.), Mechanisms of Vascular Disease (pp. 89-116). Springer International Publishing. DOI Scopus8 |
| 2020 | Fernando, S., Bursill, C. A., Nicholls, S. J., & Psaltis, P. J. (2020). Pathophysiology of Atherosclerosis. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists Third Edition (pp. 19-45). Springer International Publishing. DOI Scopus6 |
| 2017 | Lam, Y. T., Lecce, L., Bursill, C. A., & Ng, M. K. C. (2017). The Role of Sex Steroids in Angiogenesis. In Advances in Biochemistry in Health and Disease (Vol. 6, pp. 445-471). Springer International Publishing. DOI Scopus4 |
| Year | Citation |
|---|---|
| 2025 | Cartland, S., Kelland, E., Le, N., Stanley, C., Menezes, R., Murphy, M., . . . Kavurma, M. (2025). Females exhibit greater mitochondrial endothelial dysfunction, impairing vascular healing in diabetes-associated peripheral artery disease.. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 45 (pp. 2 pages). MD, Baltimore: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2025 | Cartland, S., Kelland, E., Le, N., Stanley, C., Menezes, R., Murphy, M., . . . Kavurma, M. (2025). Females exhibit greater mitochondrial endothelial dysfunction, impairing vascular healing in diabetes-associated peripheral artery disease. In ATHEROSCLEROSIS Vol. 407 (pp. 2 pages). SCOTLAND, Glasgow: ELSEVIER IRELAND LTD. |
| 2024 | Bursill, C., Pullen, B. J., Debebe, D., Sandeman, L., Wattchow, N. E., Vidanapathirana, A., . . . Packer, N. H. (2024). Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo. In Abstracts of the European Society of Cardiology Congress (ESC, 2024) as published in European Heart Journal Vol. 45 (pp. ehae6663875-1). London, England and Virtual Online: Oxford University Press. DOI |
| 2024 | Solly, E. L., Bouman Chen, Z., Luo, Y., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., . . . Tan, J. T. M. (2024). Inhibition of microRNA-181c-5p rescues diabetes-impaired angiogenesis through activation of key mediators of angiogenesis, cell survival and novel genes, elmo3 and trib1. In EUROPEAN HEART JOURNAL Vol. 45 (pp. 1 page). ENGLAND, London: OXFORD UNIV PRESS. DOI WoS1 |
| 2023 | Liyanage, S., Williamson, A., Salagaras, T., Hassanshahi, M., Long, A., Tran, D., . . . Psaltis, P. (2023). Inhibitory And Metabolic Effects Of Diabetes On Yolk Sacderived Endothelial-macrophage Progenitors In Postnatal Murine Tissues. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 43 (pp. 2 pages). PA, Philadelphia: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2022 | Solly, E. L., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., Psaltis, P. J., Bursill, C. A., & Tan, J. T. M. (2022). Inhibition of microRNA-181c rescues diabetes-impaired angiogenesis through activation of key angiogenesis mediators. In DIABETOLOGIA Vol. 65 (pp. S25-S26). Stockholm, SWEDEN: SPRINGER. |
| 2020 | Gentile, C., Kesteven, S., Wu, J., Davies, M. J., Bursill, C., Feneley, M., & Figtree, G. (2020). Endothelial nitric oxide synthase plays a protective role in endothelial cells and cardiomyocytes against myocardial infarction. In JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY Vol. 140 (pp. 31). Beijing, PEOPLES R CHINA: ELSEVIER SCI LTD. DOI |
| 2020 | Cannizzo, C., Solly, E., Olaya, L. F., Abdollahi, M., Sutanto, S. S., Twigg, S. M., . . . Mclennan, S. (2020). Inhibition of miRNA-200b Rescues Diabetes-Impaired Angiogenesis. In DIABETES Vol. 69 (pp. 2 pages). ELECTR NETWORK: AMER DIABETES ASSOC. DOI |
| 2019 | Morrison, K. R., Bursill, C., Solly, E., Shemesh, T., Nicholls, S., Brown, A. D., & Tan, J. T. M. (2019). HDL miR-181c as a Novel Biomarker for Diabetic Vascular Complications in Australian Aboriginal People. In DIABETES Vol. 68 (pp. 2 pages). San Francisco, CA: AMER DIABETES ASSOC. DOI WoS1 |
| 2019 | Gentile, C., Kesteven, S., Wu, J., Bursill, C., Davies, M. J., & Figtree, G. (2019). A Novel Cellular and Genetic Approach to Investigate the Cardioprotective Role Played by Endothelial Nitric Oxide Synthase in Myocardial Infarction. In CIRCULATION RESEARCH Vol. 125 (pp. 2 pages). Boston, MA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Khalid, A., Abraham, A. N., Bai, D., Jadhav, A., Linklater, D., Nguyen, D., . . . Gibson, B. (2019). Electrospun diamond-silk membranes for biosensing applications. In Proceedings of SPIE - The International Society for Optical Engineering Vol. 11202 (pp. 1-5). online: SPIE. DOI Scopus1 WoS1 |
| 2019 | Pisaniello, A. D., King, P., Di Bartolo, B. A., Liu, G., Gibson, R. A., Tan, J. T. M., . . . Nicholls, S. (2019). IMPACT OF FISH OIL SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN HEALTHY VOLUNTEERS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2091). New Orleans, LA: ELSEVIER SCIENCE INC. DOI |
| 2018 | Gentile, C., Kesteven, S., Wu, J., Bursill, C., Davies, M., Feneley, M., & Figtree, G. (2018). Endothelial nitric oxide synthase plays a protective role against myocardial infarction. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 128 (pp. S26). Chicago, IL: ELSEVIER SCIENCE INC. DOI WoS2 |
| 2018 | Akers, E. J., Mulangala, J., Psaltis, P. J., Bursill, C., Nicholls, S. J., & Di Bartolo, B. A. (2018). Lipoproteins and their Modified Forms Regulate Smooth Muscle Cell Calcification. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2018 | Mulangala, J., Akers, E. J., Solly, E. L., Psaltis, P. J., Tan, J. T., Nicholls, S. J., . . . Di Bartolo, B. A. (2018). Elevated Calcium Drives Inflammatory-Driven Angiogenesis. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2017 | Van Der Vorst, E., Theodorou, K., Wu, Y., Hoeksema, M., Goossens, P., Bursill, C., . . . Donners, M. (2017). HIGH DENSITY LIPOPROTEINS EXERT PRO-INFLAMMATORY EFFECTS ON MACROPHAGES VIA PASSIVE CHOLESTEROL DEPLETION AND PKC-NF-KB/STAT1-IRF1 SIGNALING. In ATHEROSCLEROSIS Vol. 263 (pp. E6). Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD. DOI WoS1 |
| 2017 | Cannizzo, C. M., Adonopulos, A. A., Ridiandries, A., Vanags, L. Z., Yuen, S. C. G., Tsatralis, T., . . . Tan, J. T. (2017). VEGFR2 is Activated by High-Density Lipoproteins and Plays a Key Role in the Pro-Angiogenic Action of HDL in Ischemia. In CIRCULATION Vol. 136 (pp. 1 page). Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2017 | Hourigan, S. T., Ridiandries, A., Tepper, E. R., Zhang, J. Q., Henriquez, R., Tsatralis, T., . . . Tan, J. T. (2017). The Regulation of miRNAs in rHDL-Induced Rescue of Diabetes-Impaired Angiogenesis. In CIRCULATION Vol. 136 (pp. 1 page). Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2015 | Robertson, S., Payet, C., Martinez, G. J., Barraclough, J., Celermajer, D., Bursill, C., & Patel, S. (2015). Colchicine Acutely Suppresses the NLRP3 Inflammasome in Acute Coronary Syndrome Patients Monocytes. In CIRCULATION Vol. 132 (pp. 2 pages). FL, Orlando: LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 2015 | Yuan, J., Rajamani, K., King, E., Bursill, C., Lecce, L., Jenkins, A., . . . Ng, M. (2015). Fenofibrate Rescues Diabetes-related Impairment of Ischaemia-mediated Angiogenesis by PPARα Independent Modulation of Thioredoxin Interacting Protein. In DIABETES Vol. 64 (pp. A114). MA, Boston: AMER DIABETES ASSOC. |
| 2014 | Robertson, S., Dababneh, E., & Bursill, C. (2014). Aldosterone-Dependent Transfer of microRNA-Containing Exosomes Between Endothelial and Smooth Muscles Cells.. In HYPERTENSION Vol. 64 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2014 | Ridiandries, A., Prosser, H., Hawkins, C., & Bursill, C. (2014). Broad-Spectrum Chemokine Inhibition Blocks Inflammation-Induced Pathological Angiogenesis but Preserves Hypoxia-Driven Physiological Angiogenesis. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 34 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. |
| 2014 | Vanags, L., Tan, J., Wise, S., Ali, Z., & Bursill, C. (2014). ApoA-I Suppresses Neointimal Hyperplasia Following Stent Deployment and Modulates Neointimal Cellular Phenotype. In CIRCULATION Vol. 130 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. |
| 2014 | Vanags, L. Z., Tan, J., Michael, J., Bilek, M., Wise, S., & Bursill, C. (2014). Immobilised apoA-I and High-Density Lipoproteins are Anti-Thrombotic and Exert Anti-Inflammatory Effects in Vascular Smooth Muscle Cells. In CIRCULATION Vol. 130 (pp. 2 pages). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS. |
| 2014 | Macer-Wright, J., Stanley, N., Tan, J., Bursill, C., & Hawkins, C. (2014). Chlorinated Nucleosides - Novel Mediators or Biomarkers of Disease?. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 76 (pp. S45-S46). ELSEVIER SCIENCE INC. DOI |
| 2013 | Macer-Wright, J., Stanley, N., Tan, J., Bursill, C., & Hawkins, C. (2013). Role of Chlorinated Nucleosides Produced by Hypochlorous Acid in the Perturbation of Cellular Function under Inflammatory Conditions. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 65 (pp. S143). ELSEVIER SCIENCE INC. DOI |
| 2008 | Ali, Z. A., Bursill, C. A., Douglas, G., McNeill, E., Papaspyridonos, M., Tatham, A. L., . . . Channon, K. M. (2008). CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis.. In Circulation Vol. 118 (pp. S71-S77). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. DOI Scopus31 WoS30 Europe PMC23 |
| 2007 | Ali, Z. A., Bursill, C. A., Papaspyridonos, M., Akhtar, A. A., Greaves, D. R., Alp, N. J., & Channon, K. M. (2007). Tetrahydrobiopterin-dependent eNOS coupling attenuates vein graft atherosclerosis through inhibition of MCP-1 mediated monocyte recruitment to sites of vascular injury. In CIRCULATION Vol. 116 (pp. 445-446). LIPPINCOTT WILLIAMS & WILKINS. |
| 2007 | Ali, Z. A., Alkhtar, A. M., Bursill, C. A., Chouchury, R. R., Greaves, D. R., & Channon, K. M. (2007). Broad spectrum adenoviral CC-chemokine blockade attenuates long term vein graft accelerated atherosclerosis in ApoE-knockout mice. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 49 (pp. 220A). LA, New Orleans: ELSEVIER SCIENCE INC. |
| 2006 | McAteer, M. A., Schneider, J. E., Ali, Z. A., Warrick, N., Bursill, C. A., von zur Muehlen, C., . . . Choudhury, R. P. (2006). Dual targeted microparticles of iron oxide detect endothelial adhesion molecule expression in mouse atherosclerosis by magnetic resonance imaging. In CIRCULATION Vol. 114 (pp. 337). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2006 | Ali, Z. A., Papaspyridonos, M., Bursill, C. A., Tatham, A. L., deBono, J. P., Bendall, J. K., . . . Channon, K. M. (2006). Increased eNOS coupling protects against vein graft accelerated atherosclerosis in ApoE-KO mice. In CIRCULATION Vol. 114 (pp. 361). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2006 | Bendall, J. K., Adlam, D., Bursill, C. A., de Bono, J., Tatham, A. L., Rinze, R., & Channon, K. M. (2006). Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: Studies in endothelial-targeted Nox2 transgenic mice. In CIRCULATION Vol. 114 (pp. 117). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| Year | Citation |
|---|---|
| 2024 | Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A. K., Rajora, M. A., Chen, J., . . . Bursill, C. A. (2024). Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease. Poster session presented at the meeting of Abstracts of the European Society of Cardiologists ESC Congress 2024, as published in European Heart Journal. London, UK: Oxford University Press. DOI WoS1 |
| 2022 | Nankivell, V. A., Vidanapathirana, A., Rajora, M., Psaltis, P., Tan, J. T., Tieu, W., . . . Bursill, C. A. (2022). Theranostic Properties of Porphysome Nanoparticles in Atherosclerotic Cardiovascular Disease. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 2022 | Primer, K. R., Tan, J. T., Psaltis, P. J., & Bursill, C. A. (2022). Pyruvate Dehydrogenase Kinase 4 is a Novel Regulator of Endothelial Cell Mitochondrial Respiration in Diabetes-Impaired Angiogenesis: Implications for Preventing Diabetic Vascular Complications. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2022 | Lotfollahi, Z., Tan, J. T., Dawson, J., Fitridge, R., & Bursill, C. A. (2022). Tracking High-Density Lipoprotein Functionality in Diabetic and Non-Diabetic Patients With Toe Amputations. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2022 | Pullen, B. J., Vidanapathirana, A. K., Sandeman, L., Everest-Dass, A., Kolarich, D., Tan, J. T., . . . Bursill, C. A. (2022). Deletion of the Asialyloglycoprotein Receptor-1 Causes Athero-Protective Effects in vitro and in vivo. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 2019 | Fernando, S., Schwarz, N., Sandeman, L., Skoumbourdis, T., Zareh, J., Williamson, A., . . . Psaltis, P. J. (2019). Eukaryotic Elongation Factor 2 Kinase Regulates Cholesterol Uptake by Macrophages via Cd36 Scavenger Receptor Expression. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Wong, N. K., Solly, E., Nicholls, S., Psaltis, P., Ng, M. K., Bursill, C. A., & Tan, J. T. (2019). <i>TRIM2</i> an<i>d CREBRF</i> Are Novel Regulators of Angiogenic Functions in Human Coronary Artery Endothelial Cells. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Akers, E. J., Mulangala, J., Wilsdon, L. A., Psaltis, P. J., Bursill, C. A., Nicholls, S. J., & Di Bartolo, B. A. (2019). Lipoproteins and Their Modified Forms Regulate Early Stage Vascular Smooth Muscle Cell Calcification. Poster session presented at the meeting of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Boston, MA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Solly, E., Hourigan, S. T., Mulangala, J., Psaltis, P. J., Di Bartolo, B., Martin, N., . . . Tan, J. T. M. (2019). Inhibition of miR-181c Rescues Diabetes-Impaired Angiogenesis. Poster session presented at the meeting of DIABETES. San Francisco, CA: AMER DIABETES ASSOC. DOI |
| 2019 | Williamson, A., Toledo, D. F., Schwarz, N., Fernando, S., Dimasi, C., Liyanage, S., . . . Psaltis, P. J. (2019). Postnatal mouse aorta contains yolk sac-derived haemangioblasts with myeloid and endothelial plasticity and vasculogenic capacity. Poster session presented at the meeting of European Heart Journal. Paris, France: Oxford University Press. |
| 2018 | Takata, K., Duong, M., Honda, S., Sidharta, S. L., Kim, S. W., Shishikura, D., . . . Nicholls, S. J. (2018). Association of Apolipoprotein C-III Distribution With Cholesterol Efflux Capacity and Coronary Plaque Burden. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2018 | Duong, M., Nankivell, V., Bursill, C. A., & Nicholls, S. J. (2018). Obesity Impairs Reverse Cholesterol Transport in Ob/Ob Mice.. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2017 | Morton, J., Bao, S., Vanags, L., Tsatralis, T., Ridiandries, A., Siu, C. -W., . . . Bursill, C. (2017). Stage-specific Effects of Apolipoprotein (apo) A-I Raising in Atherosclerosis: ApoA-I Suppresses Plaque Size and Preserves High-density Lipoprotein Function in Apo E<SUP>-/-</SUP> Mice With Early Stage <i>But Not</i> Late-stage Disease. Poster session presented at the meeting of CIRCULATION. Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2016 | Tan, J. T., Hourigan, S. T., Zhang, J. Q., Wong, N. K., Tepper, E. R., Prosser, H. C., . . . Bursill, C. A. (2016). miRNA-181c and its putative target TRIM2 mediate the ability of high density lipoproteins to rescue diabetes-impaired angiogenesis. Poster session presented at the meeting of as published in Diabetes. New Orleans, LA: American Diabetes Association. |
| 2015 | Tan, J. T. M., Prosser, H. C. G., Dunn, L. L., Vanags, L. Z., Ridiandries, A., Tsatralis, T., . . . Bursill, C. A. (2015). High Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor-BI and Restoration of VEGF and HIF-1 alpha Stability. Poster session presented at the meeting of DIABETES. Boston, MA: AMER DIABETES ASSOC. WoS1 |
| 2014 | Van der Vorst, E. P. C., Theodorou, K., Plat, J., Van Eck, M., Rye, K. A., Bursill, C. A., . . . Donners, M. M. P. C. (2014). High density lipoproteins exert pro-inflammatory effects on macrophages via IKK2-and NIK-independent NF-kB activation. Poster session presented at the meeting of CARDIOVASCULAR RESEARCH. Barcelona, SPAIN: OXFORD UNIV PRESS. DOI |
| 2013 | Prosser, H. C., Tan, J. T., Dunn, L. L., Patel, S., Vanags, L. Z., Monger, S., . . . Bursill, C. A. (2013). Multifunctional Regulation of Angiogenesis by High Density Lipoproteins. Poster session presented at the meeting of CIRCULATION. Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. |
| 2013 | Morton, J., Bao, S., Celermajer, D. S., Ng, M. K., & Bursill, C. A. (2013). Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early-Stage Versus Late-Stage Atherosclerosis. Poster session presented at the meeting of CIRCULATION. Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2012 | Quigley, A. F., Summers, F. A., Barrett, T. J., Bursill, C. A., & Hawkins, C. L. (2012). A novel role of myeloperoxidase in the induction of endoplasmic reticulum (ER) stress. Poster session presented at the meeting of FREE RADICAL BIOLOGY AND MEDICINE. ELSEVIER SCIENCE INC. DOI |
| 2012 | Quigley, A. F., Summers, F. A., Barrett, T. J., Bursill, C. A., & Hawkins, C. L. (2012). A Novel Role for Myeloperoxidase in the Induction of C/EBP-Homologous Protein (CHOP). Poster session presented at the meeting of FREE RADICAL BIOLOGY AND MEDICINE. San Diego, CA: ELSEVIER SCIENCE INC. DOI |
| Year | Citation |
|---|---|
| 2025 | Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a novel murine model of in-stent neoatherosclerosis. DOI |
| 2025 | Xiang, L., Chen, R., Tan, J., Nankivell, V., Bursill, C. A., McLaughlin, R. A., & Li, J. (2025). Identification and Removal of System-Induced Autofluorescence in Miniaturized Fiber-optic Fluorescence Endoscopes. |
| 2024 | Wong, N. K. P., Solly, E., Le, R., Nankivell, V., Mulangala, J., Psaltis, P., . . . Tan, J. T. M. (2024). TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. DOI |
| 2024 | Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A., Rajora, M., Chen, J., . . . Bursill, C. (2024). Multifunctional biomimetic porphyrin-lipid nanoparticles – novel nanoscale theranostics for atherosclerotic cardiovascular disease. DOI |
| 2024 | Ruchka, P., Kushwaha, A., Marathe, J. A., Xiang, L., Chen, R., Kirk, R., . . . Li, J. (2024). 3D-printed axicon enables extended depth-of-focus intravascular optical coherence tomography. |
| 2024 | Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V., Stretton, L. G., Solly, E., . . . Bursill, C. (2024). Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia. DOI |
·National Heart Foundation Lin Huddleston Foundation Fellowship (2017-2022)
Chief Investigator: Christina Bursill (CIA)
Amount: ~$750,000 over 5 years
·Diabetes Australia Research (DART) grant (2017)
Title: ‘Micromanaging’ high-density lipoprotein-induced rescue of diabetes-impaired angiogenesis
Chief Investigators: Joanne Tan and Christina Bursill
Amount: $60,000
· NAB Career Re-start Grant (2016)
Title: Reversing the progression of atherosclerosis
Chief Investigators: Christina Bursill (CIA),
Amount: $60,000 over one year
· ARC Discovery Grant (2016)
Title: Dynamics of atherosclerotic plaque formation, growth and regression
Chief Investigators: Mary Myerscough (CIA), Charlie Macaskill (CIB), Christina Bursill (PI).
Amount: $218,768 over three years
· University of Sydney - Thompson Fellowship (2016)
Title: Using the "Good Cholesterol" to increase stent longevity
Chief Investigator: Christina Bursill (CIA)
Amount: $90, 000 over one year
· University of Sydney Bridging Grant (2015)
Title: Different athero-protective properties of HDL in early versus late atherosclerosis
Chief Investigators: Christina Bursill (CIA)
Amount: $30, 000 over 1 year
· NHMRC Project Grant (2015)
Title: Oxidative Regulation of the Na pump – a new player in vascular function in health and disease.
Chief Investigators: Gemma Figtree (CIA), Christina Bursill (CIB), A/Prof Ravinay Bhindi (CIC), Prof Keith Channon (CID), A/Prof Clare Hawkins (CIE), Dr Ben Davies (CIF), Prof Richard Cohen (CIG).
Amount: $488,816 over three years
· University of Sydney Bridging Grant (2013)
Title: Differential Regulation of Angiogenesis by CC-Chemokines
Chief Investigators: Christina Bursill (CIA)
Amount: $30, 000 over 1 year
· NHMRC project grant (2010-2013)
Title: Multifunctional regulation of Angiogenesis by High Density Lipoproteins
Chief Investigators: Martin Ng (CIA), Christina Bursill (CIB)
Amount: $476, 000 over 3 years
· Heart Foundation Career Development Fellowship (2008-2013)
Title: The Role of Chemokines in the Anti-Atherosclerotic Effects of HDL
Chief Investigator: Christina Bursill
Amount: $515,000 – includes 5 years salary, travel funds and equipment support.
·Bushell Foundation (2008-2011)
Title: Understanding the Anti-Atherosclerotic Properties of High Density Lipoproteins
Investigator: Christina Bursill
Amount: $250, 000 over 3 years
· British Heart Foundation Program Grant (2005-2007):
Title: Evaluation of Broad Spectrum Chemokine agonists to Inhibit Atherosclerosis
Investigators: Keith Channon, David Greaves, and Christina Bursill
Amount: £715,961 over 5 years
· British Heart Foundation Project Grant (2001-2004):
Title: Evaluation of Broad Spectrum CC-Chemokine antagonists to Inhibit Inflammatory Cell Recruitment in Atherogenesis.
Investigators: David Greaves, Keith Channon, and Christina Bursill
Amount: £152,326 over 3 years. Based on the success of the project, the initial grant was extended for a further 2.5 years (£126,939) based on my research.
Undergraduate Teaching:
·1997-98: Tutor for 1st year Medical students in Problem Based Learning, Department of Medicine, University of Adelaide.
·1998-2000: Demonstrator for 2nd year Science students in Cardiovascular Physiology, Department of Physiology, University of Adelaide.
·2001: Lecturer to 2nd year Medical students on Lipoprotein Metabolism, Department of Pathology, University of Oxford, UK.
·2001, 2002: Demonstrator for 2nd year Medical Students in Atherosclerosis and Thrombosis, Department of Pathology, University of Oxford, UK.
·2004-2006: Lecturer to 3rd year Medical students in ‘Methods and Approach in Scientific Research’. Department of Medicine, University of Oxford, UK.
·2015-2026: Lecturer to 3rd year Physiology students on “Vascular Inflammation”, University of Sydney, NSW.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Co-Supervisor | Mathematical modelling of plaque calcification in atherosclerosis | Master of Philosophy | Master | Full Time | Miss Faith Caren Thando Penn Sawers |
| 2025 | Co-Supervisor | Exploring novel approaches to residual inflammation in coronary artery disease | Doctor of Philosophy | Doctorate | Full Time | Dr Rajesh Pathy |
| 2024 | Principal Supervisor | Deletion of the asialoglycoprotein receptor 1 (ASGR1) to prevent athersclerotic cardiovascular disease | Doctor of Philosophy | Doctorate | Full Time | Mr Liam George Stretton |
| 2023 | Principal Supervisor | The role of the asialoglycoprotein receptor-1 in immune cell regulation of atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Mr Demeke Geremew Debebe |
| 2023 | Co-Supervisor | New Predictive Factors that Drive Coronary Artery Disease | Doctor of Philosophy | Doctorate | Full Time | Miss Naomi Elizabeth Wattchow |
| 2023 | Co-Supervisor | The Evaluation and Validation of Autophagy as a Novel Biomarker of Coronary Artery Disease | Doctor of Philosophy | Doctorate | Part Time | Dr Mau Tam Nguyen |
| 2022 | Co-Supervisor | Multimodal imaging probe for atherosclerotic plaque detection | Doctor of Philosophy | Doctorate | Full Time | Miss Rouyan Chen |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2019 - 2023 | Principal Supervisor | The Role of Endothelial Cell Metabolic Reprogramming in Diabetes impaired Angiogenesis | Doctor of Philosophy | Doctorate | Full Time | Miss Khalia Rose Primer |
| 2019 - 2023 | Co-Supervisor | MicroRNA-181c-5p - A Novel Therapeutic Target for the Rescue of Diabetes-Impaired Angiogenesis | Doctor of Philosophy | Doctorate | Full Time | Miss Emma Louise Solly |
| 2019 - 2023 | Co-Supervisor | Inhibitory and metabolic effects of diabetes on yolk sac-derived endothelial-macrophage progenitors in postnatal murine tissues | Doctor of Philosophy | Doctorate | Full Time | Ms Sanuri Rashmitha Liyanage |
| 2018 - 2022 | Co-Supervisor | Discovery and characterisation of yolk-sac derived Endothelial-Macrophage progenitor cells in postnatal murine tissues | Doctor of Philosophy | Doctorate | Full Time | Miss Anna Emilie Williamson |
| 2018 - 2022 | Principal Supervisor | The Anti-Inflammatory and Pro-Angiogenic Capacity of High-Density Lipoproteins in Diabetic Wound Healing | Doctor of Philosophy | Doctorate | Full Time | Ms Zahra Lotfollahi |
| 2018 - 2023 | Principal Supervisor | Investigating the theranostic properties of apoA-I-linked porphyrin-lipid nanoparticles in atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Miss Victoria Ann Nankivell |
| 2018 - 2023 | Principal Supervisor | The role of Asialoglycoprotein Receptor-1 in Atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Mr Benjamin James Pullen |
| 2017 - 2021 | Co-Supervisor | Vascular Calcification as a Risk Factor for Peripheral Arterial Disease and its Effects on Angiogenesis | Doctor of Philosophy | Doctorate | Full Time | Ms Jocelyne Mulangala |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2021 - ongoing | Board Member | International Atherosclerosis Society | International Atherosclerosis Society | United States |
| 2020 - 2023 | Treasurer | Australian Cardiovascular Alliance | Australian Cardiovascular Alliance | Australia |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2023 - ongoing | Co-Chair | SA Cardiovascular Research Network | Heart Foundation | Australia |
| 2018 - ongoing | President | Australian Atherosclerosis Society | N/A | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2014 - ongoing | Associate Editor | Journal of Biochemistry | - | - |
| 2013 - ongoing | Associate Editor | PLoS ONE | - | - |
Connect With Me
External Profiles
